Skip to main content
S 3211 114th Congress Senate Health Cancer Cardiovascular and respiratory health Digestive and metabolic diseases Drug therapy Emergency medical services and trauma care Health care quality Health information and medical records Home and outpatient care Long-term, rehabilitative, and terminal care Medicare Performance measurement Women's health

Cancer Care Payment Reform Act of 2016

Introduced: July 14, 2016 Introduced by: Cornyn, John Republican · Texas See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 14, 2016
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S5163-5165)
Jul 14, 2016
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Cancer Care Payment Reform Act of 2016

This bill amends title XVIII (Medicare) of the Social Security Act to establish the Oncology Medical Home Demonstration Project, through which the Centers for Medicare & Medicaid Services (CMS) shall make special payments to participating oncology practices that coordinate patient care and meet other specified requirements.

During the first two years of the project, CMS shall pay a care coordination management fee to each such practice. After the third, fourth, and fifth years of the project, CMS shall pay a performance incentive payment to each participating practice that meets or exceeds performance standards developed by CMS.

CMS shall assess the performance of each participating oncology practice annually. Performance standards shall address: (1) specified measures related to patient care, resource utilization, survivorship, and end-of-life care; and (2) the patient experience of care, as reflected in surveys submitted by each practice. CMS shall also assess the extent to which a practice has used breakthrough or other best-in-class therapies.

To the extent practicable, CMS shall select practices of varying sizes and geographic areas for participation.

What's happening now July 14, 2016

Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S5163-5165)

 Related & companion bills 1
  • HR 1934 Related bill Cancer Care Payment Reform Act of 2015
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3211: Cancer Care Payment Reform Act of 2016. 114th Congress. Open America. https://openamerica.io/bill/114-S-3211/
MLA
"S. 3211: Cancer Care Payment Reform Act of 2016." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-S-3211/.
Bluebook (legal)
S. 3211, 114th Cong. (2026), https://openamerica.io/bill/114-S-3211/.
Markdown link
[S. 3211: Cancer Care Payment Reform Act of 2016](https://openamerica.io/bill/114-S-3211/)
Report a problem